IFP Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.98M | Buy |
8,216
+643
| +8% | +$220K | 0.05% | 381 |
|
|
2026
Q1 | $2.66M | Sell |
7,573
-4,407
| -37% | -$1.57M | 0.06% | 368 |
|
|
2025
Q4 | $3.92M | Buy |
11,980
+3,861
| +48% | +$1.22M | 0.09% | 242 |
|
|
2025
Q3 | $2.29M | Buy |
8,119
+725
| +10% | +$210K | 0.06% | 345 |
|
|
2025
Q2 | $2.13M | Buy |
7,394
+483
| +7% | +$137K | 0.06% | 345 |
|
|
2025
Q1 | $2.15M | Buy |
6,911
+809
| +13% | +$239K | 0.07% | 342 |
|
|
2024
Q4 | $1.59M | Buy |
6,102
+357
| +6% | +$106K | 0.05% | 396 |
|
|
2024
Q3 | $1.85M | Sell |
5,745
-3,261
| -36% | -$1.07M | 0.07% | 320 |
|
|
2024
Q2 | $2.81M | Buy |
9,006
+4,875
| +118% | +$1.43M | 0.11% | 192 |
|
|
2024
Q1 | $1.17M | Buy |
4,131
+134
| +3% | +$39.2K | 0.05% | 378 |
|
|
2023
Q4 | $1.15M | Sell |
3,997
-164
| -4% | -$44.7K | 0.05% | 355 |
|
|
2023
Q3 | $1.12M | Sell |
4,161
-2,076
| -33% | -$518K | 0.05% | 364 |
|
|
2023
Q2 | $1.38M | Buy |
6,237
+45
| +0.7% | +$10.4K | 0.06% | 341 |
|
|
2023
Q1 | $947K | Sell |
6,192
-5,165
| -45% | -$1.27M | 0.04% | 408 |
|
|
2022
Q4 | $1.78M | Sell |
11,357
-152
| -1% | -$40.7K | 0.05% | 410 |
|
|
2022
Q3 | $1.8M | Buy |
11,509
+1,475
| +15% | +$358K | 0.05% | 437 |
|
|
2022
Q2 | $1.56M | Hold |
10,034
| – | – | 0.05% | 432 |
|
|
2022
Q1 | $1.56M | Buy |
10,034
+4,997
| +99% | +$1.15M | 0.05% | 432 |
|
|
2021
Q4 | $1.14M | Sell |
5,037
-234
| -4% | -$49.4K | 0.02% | 376 |
|
|
2021
Q3 | $1.13M | Buy |
5,271
+1,607
| +44% | +$370K | 0.02% | 373 |
|
|
2021
Q2 | $895K | Buy |
3,664
+335
| +10% | +$82.4K | 0.02% | 396 |
|
|
2021
Q1 | $820K | Sell |
3,329
-664
| -17% | -$158K | 0.02% | 390 |
|
|
2020
Q4 | $916K | Sell |
3,993
-383
| -9% | -$88.3K | 0.04% | 366 |
|
|
2020
Q3 | $1.11M | Sell |
4,376
-142
| -3% | -$35.2K | 0.07% | 270 |
|
|
2020
Q2 | $1.04M | Sell |
4,518
-301
| -6% | -$68.7K | 0.08% | 251 |
|
|
2020
Q1 | $957K | Buy |
4,819
+247
| +5% | +$54K | 0.1% | 220 |
|
|
2019
Q4 | $1.1M | Buy |
4,572
+695
| +18% | +$153K | 0.08% | 258 |
|
|
2019
Q3 | $757K | Buy |
+3,877
| New | +$744K | 0.05% | 373 |
|
|
2019
Q1 | $534K | Sell |
2,823
-11,180
| -80% | -$2.14M | 0.07% | 275 |
|
|
2018
Q4 | $2.67M | Sell |
14,003
-1,932
| -12% | -$377K | 0.16% | 143 |
|
|
2018
Q3 | $3.3M | Buy |
15,935
+670
| +4% | +$132K | 0.13% | 176 |
|
|
2018
Q2 | $2.82M | Sell |
15,265
-2,089
| -12% | -$370K | 0.12% | 194 |
|
|
2018
Q1 | $3.02M | Hold |
17,354
| – | – | 0.14% | 170 |
|
|
2017
Q4 | $3.02M | Sell |
17,354
-4,533
| -21% | -$802K | 0.14% | 170 |
|
|
2017
Q3 | $4.08M | Buy |
21,887
+209
| +1% | +$37K | 0.16% | 137 |
|
|
2017
Q2 | $3.73M | Sell |
21,678
-1,993
| -8% | -$324K | 0.16% | 139 |
|
|
2017
Q1 | $3.88M | Buy |
23,671
+3,774
| +19% | +$627K | 0.17% | 133 |
|
|
2016
Q4 | $2.91M | Buy |
19,897
+2,789
| +16% | +$420K | 0.14% | 164 |
|
|
2016
Q3 | $2.85M | Buy |
17,108
+3,022
| +21% | +$511K | 0.15% | 151 |
|
|
2016
Q2 | $2.14M | Buy |
14,086
+11,263
| +399% | +$1.75M | 0.12% | 190 |
|
|
2016
Q1 | $534K | Sell |
2,823
-12,622
| -82% | -$1.88M | 0.07% | 275 |
|
|
2015
Q4 | $2.51M | Buy |
+15,445
| New | +$2.43M | 0.17% | 127 |
|
Other funds holding AMGN
IFP Advisors's AMGN Position: Q2 2026 in Review
IFP Advisors increased its Amgen (AMGN) stake by 8.5% in Q2 2026, buying an estimated $220K and bringing the position to 8,216 shares worth $2.98M. The position accounts for 0.05% of the portfolio, ranked #381.
IFP Advisors first reported a position in AMGN in Q4 2015 and has held it in 42 quarters since. The position peaked at $4.08M in Q3 2017. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- IFP Advisors held 8,216 shares of Amgen worth $2.98M as of Q2 2026.
- IFP Advisors bought 643 Amgen shares in Q2 2026, an estimated $220K.
- Amgen made up 0.05% of IFP Advisors's portfolio in Q2 2026, its #381 holding.
- IFP Advisors first reported a position in Amgen in Q4 2015 and has held it in 42 quarters since.
- IFP Advisors's Amgen position peaked at $4.08M in Q3 2017.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.